Tag: DNA
Study provides new insights into drug-resistant Tuberculosis
Indian researchers have identified compromised DNA repair as important for the emergence of drug resistance in Mtb
Researchers devise field deployable alternative to RT-PCR
The newly developed ‘Recombinase Polymerase Amplification (RPA)’ method, wherein all the reactions take place close to room temperature, does not require a thermal cycler
CSIR-CDRI launches new Make-in-India product GreenR™: A nucleic acid staining dye for biomedical...
GreenR is highly versatile and binds to all nucleic acids including genomic DNA, PCR products, plasmids and RNA
India gets first of its kind Centre of Excellence for DNA...
Amit Shah, Minister of Home Affairs and Minister of Co-operation, Govt. of India inaugurated India’s first Centre of Excellence for DNA Forensics set up by National Forensic Sciences University in technical collaboration with Thermo Fisher Scientific
CSIR-CDRI transfers technology of a nucleic acid staining ‘dye GreenR’
The development of this indigenous dye will offer the Indian researcher an alternative to expensive imported dyes made by foreign MNCs
World is on the cusp of making a technological shift: Alex...
mRNA vaccines have been possible because we digitized the genomic information from the virus itself, stated Alex Gorsky, Executive Chairman, Johnson & Johnson.................
“We need to have better understanding of gut microbiome”
In an interaction with the BioVoice News, Dr Surendra K Chikara, the Founder and CEO of Bione shared details on the company's activities, key milestones and future plans.
Treatment of progressive neurological, neuromuscular disorder gets a shot in the...
The researchers identified the compounds from a library of about 25 lakh small molecules maintained by the National Cancer Institute (NCI), United States of America
Scientists develop new technology platform to detect SARS-CoV-2
A highlight of the study is that it presents an entirely new strategy to target a unique, unconventional nucleic acid structure specific to the SARS-CoV-2 sequence using small molecules
HaystackAnalytics develops India’s first Universal Infectious Disease Genomic Test
Tests to be rolled out over the next three months in partnership with hospitals and diagnostic centres across the country, initially targeted at ICU patients in hospitals